Who We Are
Genericlab is one of the first Algerian private pharmaceutical laboratories. Founded in 1992 and located in Rouïba, in the largest Industrial Zone in Algeria, Genericlab’s mission is to meet the specific development needs of generic drugs in the country.
Significant investments have been made since the creation of Genericlab, in particular thanks to various partnerships concluded with international laboratories, thus enabling the company to acquire a solid technological base in terms of “GMP” Good Manufacturing practices, in order to provide the Algerian patient with quality products and facilitate access to care.
All of Genericlab’s teams adopt a common development strategy, consisting of tackling different market segments in order to diversify, while respecting the values of the company defined by General Direction .
Nearly 300 highly qualified people work actively and in strict compliance with manufacturing procedures.
Genericlab is also more than 54 products of various specialties: Ophthalmology, Neuropsychiatry, Allergology, Cardiology, Pediatrics, Gastroenterology, Endocrino-diabetology, Food supplements, Rheumatology, Orthopedics and Urology.
A wide range of products meeting the needs of patients.
Formerly named PHDH, SARL Genericlab was an establishment specialized in the manufacture of hospital sanitizers and decontaminants under license of Peters laboratories (Products intended for the fight against nosocomial infections).
Genericlab is born with a new vision and new objectives. With the change in activity, by tackling the import and manufacture of generic drugs, it aims to be the benchmark for generic drugs in Algeria.
This year marks the launch of the 1st shaped drug (subcontracted to SAIDAL GROUPE), as well as the creation of a marketing department and a network of medical representatives in partnership with the Swiss laboratory MEPHA.
Genericlab began building a drop manufacturing unit in partnership with an Italian COPHITAL laboratory. This project was named GENCOPHARM, a mixed company under Algerian law.
Start of the dry form workshops in March 2010.
Start of liquid form workshops in February 2014
Residency, St. Harvard University Hospital
Genericlab takes a big step forward and invests in the manufacture of a large unit dedicated to the production of eye drops, making it the first laboratory to locally produce eye drops in Algeria. This new positioning has brought her , after only three years, the second place in the ophthalmology market.
Genericlab is expanding its know-how by launching into the production of food supplements, by marketing a range of DOLPINA products for children and adults.
The company received support for the implementation of: